Sidra Medicine, a Qatar Basis entity, has appointed Dr Barbro Friden as its main govt officer. She has extensive practical experience in equally the community and private health care sectors in Sweden and the Center East. Prior to joining Sidra Drugs, Dr Friden was the CEO of Sheikh Khalifa Medical Town in Ajman and just before that, the CEO of Sahlgrenska University Medical center, Scandinavia’s greatest educating hospital. She was beforehand the clinic director of the Children’s Hospital at Karolinska University Healthcare facility in Sweden.
Mohammed Khalid al-Mana, running director and member of the Board of Governors at Sidra Drugs reported, “We are delighted to have Dr Barbro Friden join us at Sidra Drugs. Her leadership expertise in obstetrics and gynaecology and working experience in getting led women’s and children’s hospitals in Sweden will be a incredible asset to our client treatment design as we embark on strengthening and increasing our companies in Qatar. We glance forward to Dr Friden’s stewardship over the following chapter of our journey towards obtaining our all round eyesight of turning into a beacon of finding out, discovery and fantastic care.”
Dr Friden noted, “Together with our numerous multidisciplinary groups, I look ahead to constructing on Sidra Medicine’s legacy of delivering high-quality treatment and a personalised individual encounter with great health-related outcomes created on a sturdy research foundation of precision drugs.”
Dr Friden is nicely recognised within just her area owning gained ‘Leader of the Year’, a nationwide award in Sweden in 2015 as nicely as ‘Influencer of the Year’ in 2014, a lifetime science organization countrywide award. Dr Friden sits on the board on a selection of authorities and business boards linked to health care including a major medtech business and Sophiahemmet, a non-financial gain healthcare supplier under royal stewardship that conducts schooling, health care and investigate.
Dr Friden received her medical diploma from Umea University in Sweden, specialising in obstetrics and gynaecology with a subspecialty in reproductive drugs and IVF. She was also a viewing exploration fellow in reproductive drugs at the University of California. She retains a PhD in Medication from Gothenburg College.